Skip to main navigation Skip to search Skip to main content

A Phase 1/2a Study of BMS-986205 Administered in Combination with Nivolumab (BMS-936558, anti-PD-1 Monoclonal Antibody) in Advanced Cancers

  • Markman, Ben (Primary Chief Investigator (PCI))
  • Day, Daphne (Chief Investigator (CI))
  • Body, Amy (Partner Investigator (PI))

Project: Research

Project Details

Project Description

NMA Reference Number: HREC/16/MH/14
SSA Reference Number: SSA/16/MonH/373
Monash Health HREC Ref: RES-16-0000557X
StatusFinished
Effective start/end date29/01/19 → 28/01/24

Clinical Trial Phase

  • Phase I
  • Phase II